8:00 AM to 8:30 AM
REGISTRATION
8:30 AM to 8:45 AM
AGENDA
8:45 AM to 10:00 AM
SESSION 1- AFFORDABLE CANCER CARE-CURRENT STATUS?
SPEAKERS | AFFORDABLE CANCER CARE - AN ONCOLOGIST'S PERSPECTIVE | DR SAMEER KAUL | Sr Consultant Surgical Oncology & ROBOTICS, Apollo Cancer Institute |
SPEAKERS | AFFORDABLE CANCER CARE - ARE WE THERE? - PHARMA & BIOTECH PERSPECTIVE | PROF. PARTHA P MAJUMDER | Department of Biotechnology, Govt. of India |
SPEAKERS | AFFORDABLE CANCER CARE FOR INDIANS - A POLICY MAKER'S INSIGHT | MR. SUDHANSHU PANDEY | Joint Secretary, Department of Commerce, Ministry of Commerce and Industry, Govt. Of India |
PANEL DISCUSSION & RECOMMENDATIONS - SESSION 1 | |||
Chairperson | SHRI. SUDHANSH PANT | Joint Secretary (Policy), Department of Pharmaceuticals | |
Moderator | PROF G.K. RATH | Chief, B.R.A. IRCH, All India Institute Of Medical Sciences | |
Panelist 1 | PROFESSOR (DR) V. K. PAUL, | Member, NITI Aayog | |
Panelist 2 | DR. G. N. SINGH | Drug Controller General of India, Ministry of Health & Family Welfare | |
Panelist 3 | MR. BHAGOJI T. KHANAPURE | Drugs Controller, DCD, Govt. of Karnataka | |
Panelist 4 | DR. ANIL KUKREJA | Medical Director, Roche Pharmaceuticals | |
Panelist 5 | MR. MANISH BAJAJ | Vice President, Strategy, Portfolio Management & Innovation Dr. Reddy’s, Global Generics - India | |
Panelist 6 | MR DEEPAK BAGLA | CEO - Invest India | |
Panelist 7 |
10:00 AM to 10:30 AM
INAUGURATION & WELCOME PRESIDENTIAL ADDRESS
10:30 AM to 11:45 AM
SESSION 2 – INDUSTRY CONCERNS & REMEDIES
SPEAKERS | ORPHAN DRUGS AND THEIR RELEVANCE IN CANCER CARE INDIA | MR. AMITABH DUBE | Business Unit Head Novartis India Ltd |
SPEAKERS | BIOSIMILARS IN ONCOLOGY – JUST THE RIGHT WAY FORWARD | RAKESH BAMZAI | CEO, MD, President (India & Emerging Markets), Mylan Laboratories Ltd |
SPEAKERS | TAXATION FOR ONCOLOGY PRODUCTS IN INDIA NEEDS REVISITING | V. LAKSHMI KUMARAN | Founder and Managing Partner Lakshmikumaran & Sridharan |
PANEL DISCUSSION & RECOMMENDATIONS - SESSION 2 | |||
Chairperson | MR VINOD RAINA | Executive Director, Fortis Memorial Research Institute Gurgaon | |
Moderator | DR. ASHOK VAID | Chairman, Medical & Paediatric Oncology, Medanta | |
Panelist 1 | DR. SANJIT SINGH LAMBA | Managing Director, Eisai Pharmaceuticals India Pvt Ltd | |
Panelist 2 | DR. P.K.JULKA | Senior Director & Medical Oncologist, Max Healthcare | |
Panelist 3 | DR. J S THAKUR | Professor of Community Medicine, PGI | |
Panelist 4 | DR ROHIT NAYYAR | Sr Consultant Surgical Oncology | |
Panelist 5 | DR. JAIDEEP GUPTA | MD - Apollo Hospitals | |
Panelist 6 | Dr.(Maj Gen) S.C.PAREEK | Director, Bhagwan Mahaveer Cancer Hospital & Research Centre | |
Panelist 7 | DR H.G KOSHIA | Commissioner FDCA |
11:45 AM to 1:00 PM
SESSION 3 – INDIGENOUS RESEARCH & DEVELOPMENT
SPEAKERS | IMPETUS TO RESEARCH & DEVELOPMENT IN INDIA IS WANTING | DR. SHYAM AGARWAL | Chairman Oncology. Sir Ganga Ram Hospital, Delhi |
SPEAKERS | CHALLENGES & OPPORTUNITIES IN RESEARCH FOR AFFORDABLE CANCER CARE IN INDIA | DR. JITENDAR KUMAR SHARMA | Advisor (Health), Govt. of Andhra Pradesh MD & CEO - AMTZ |
SPEAKERS | A PUBLIC PRIVATE PARTICIPATION FOR CANCER PREVENTION | DR. SWATI A PIRAMAL | Vice Chairperson, Piramal Enterprises Ltd. |
PANEL DISCUSSION & RECOMMENDATIONS - SESSION 3 | |||
Chairperson | MR HEMANT BATRA | Director, Batra Group and Hospitals | |
Moderator | DR DEEPALI KAPOOR | Onco-Psychologist Apollo Cancer Institute | |
Panelist 1 | DR. SHEKHAR SALKAR | Sr Consultant Surgical Oncology, Manipal Hospital, Goa | |
Panelist 2 | MR. MANOJ PANANCHUKUNNATH | Head of Global Injectables Scientific Affairs, Mylan Laboratories Limited Bangalore | |
Panelist 3 | MR. DAVINDER SINGH BRAR | Chairman, GVK Biosciences Private Limited, | |
Panelist 4 | DR. RAJAT GOYAL | Country Director - India, International AIDS Vaccine Initiative | |
Panelist 5 | MR. SURESH RAMU | Co-Founder & CEO, Cytecare Hospitals | |
Panelist 6 | DR THOMAS VARUGHESE | Director Cancer Division, Sr. Consultant & HoD, Surgical Oncology & Reconstructive Surgery, Renai Medicity Hospital | |
Panelist 7 | DR B S SRINATH | Sr Consultant Surgical Oncology, Sri Shankara Cancer Foundation |
1:00 PM to 2:00 PM
LUNCH BREAK
2:00 PM to 3:15 PM
SESSION 4 – EARLY STANDARD CURRENT DIAGNOSTICS
SPEAKERS | CANCER DIAGNOSTICS – CURRENT STATUS AND AFFODABILITY | DR. NITESH ROHATGI | MEDICAL ONCOLOGIST, Max Healthcare | |
SPEAKERS | AFFORDABLE EARLY DIAGNOSIS – A CHALLENGE FOR GOVERNMENT | DR. RAVI MEHROTRA | Director, National Institute of Cancer Prevention & Research | |
SPEAKERS | IMPROVING ACCESS TO CANCER DIAGNOSTICS: ENTREPRENEURIAL STRATEGIES | Ms. ZOYA BRAR | Founder & Managing Director, CORE Diagnostics | |
PANEL DISCUSSION & RECOMMENDATIONS - SESSION 4 | ||||
Chairperson | DR. R.K. VYAS | DR.R.K. VYAS, Prof & HOD, Radiation Oncology & DIRECTOR | ||
Moderator | DR. HARSH MAHAJAN | Founder & Chief Radiologist, Mahajan Imaging | ||
Panelist 1 | DR. SANJEEV MISRA | Director & CEO, All India Institute of Medical Sciences | ||
Panelist 2 | DR. GOVIND BABU | Sr Consultant Surgical Oncology, HCG Bangalore Institute of Oncology Specialty Centre | ||
Panelist 3 | DR. J S SEKHON | Sr. Consultant Medical Oncology, Ludhiana, | ||
Panelist 4 | DR. SANKAR SRINIVASAN | Consultant Medical Oncology, Apollo Specialty Cancer Hospital | ||
Panelist 5 | DR. REENA NAIR | Sr. Consultant, Clinical Hematology, Tata Medical Centre | ||
Panelist 6 | DR. MANJIRI BAKRE | Founder and CEO, OncoStem Diagnostics Pvt | ||
Panelist 7 | MR. SATISH DESHPANDE | Strategy Consultant, Datar Genetics Limited |
3:15 PM to 3:30 PM
TEA BREAK
3:30 PM – 05:00 PM
SESSION 5 – PATIENT EDUCATION, ADVOCACY GROUPS & ROLE OF MEDIA
SPEAKERS | PATENT RIGHTS FOR HEALTH CARE PRODUCTS IN INDIA | MR. PRAVIN ANAND | Managing Partner , Anand & Anand | |
SPEAKERS | FAMILY ECOSYSTEM IN CANCER CARE | MR. Y.K. SAPRU | Founder Chairman & CEO, CPAA | |
SPEAKERS | VALUE BASED CANCER CARE IN INDIA | Dr. B S AJAIKUMAR | Chairman & CEO, HealthCare Global Enterprises Limited | |
SPEAKERS | PUBLIC PRIVATE PARTNERSHIPS - TOWARDS BUILDING OPTIMUM AND AFFORDABLE CANCER CARE | Ms FRANCES MILNES | Head, Market Access, Emerging Growth Markets, Novartis | |
PANEL DISCUSSION & RECOMMENDATIONS - SESSION 5 | ||||
Chairperson | Prof K.S. GOPINATH | Director & Surgical Oncologist, HCG, Bangalore Institute of Oncology, Ambuja Health Care | ||
Moderator | MS SANCHITA SHARMA | Sr. Health Editor, Hindustan Times | ||
Panelist 1 | DR. SANDEEP GOYLE | Consultant, Medical Oncology, Kokilaben Dhirubhai Ambani Hospital | ||
Panelist 2 | DR. CHANCHAL GOSWAMI | Sr Consultant Medical Oncologist, B P Poddar Hospital and Medical Research Ltd | ||
Panelist 3 | DR S. HUKKU | Sr. Consultant & Chairman, Radiation Oncology, BLK Super Speciality Hospital | ||
Panelist 4 | DR. JAGDISH PRASAD | Director General of Health Services, Ministry of Health & Family Welfare, | ||
Panelist 5 | DR. Y. INDIBOR SINGH | Professor, Dept of Radiation Oncology, Regional Institute of Medical Sciences, | ||
Panelist 6 | DR SANAULLAH KUCHAY | Professor & Head, Dept of Radiation Oncology, GMC | ||
Panelist 7 | varian |
5:00 PM – 6:15 PM
SESSION 6 – THERAPY PRICING, INSURANCE & COPAY
SPEAKERS | PRICING FOR CANCER CARE IN INDIA - PRACTICALITY & AFFORDABILITY | MR. BHUPENDRA SINGH | Chairman, National Pharmaceutical Pricing Authority |
SPEAKERS | HEALTH INSURANCE FOR CANCER TREATMENT - PRODUCTS AVAILABLE, EVOLUTION | MS. SHOBANA KAMINENI | President, CII |
SPEAKERS | GOVERNMENT POLICIES IN AFFORDABLE CANCER CARE: “PRESENT & FUTURE – A 20 YEAR OVERVIEW” | MR. AMITABH KANT | CEO, Niti Aayog |
PANEL DISCUSSION & RECOMMENDATIONS - SESSION 6 | |||
Chairperson | DR S.H. ADVANI | Director of Medical Oncology, Haematology, Jaslok Hospital and Medical Research Institute | |
Moderator | MS. FATIMA MAHDI KARAN | Consulting Editor, BTVi | |
Panelist 1 | DR SUDHIR GUPTA | Addl. Deputy Director General, Ministry of Health & Family Welfare | |
Panelist 2 | MR NAVDEEP RINWA | Joint Secretary, Ministry of Health & Family Welfare | |
Panelist 3 | DR ASHUTOSH GUPTA | Sr Consultant Radiation Oncology, Department of Radiotherapy, Medical College | |
Panelist 4 | DR. AJAY BAPNA | Sr. Consultant & HOD, Medical Oncology, Bhagwan Mahaveer Cancer Hospital & Research Centre | |
Panelist 5 | DR. ULLAS BATRA | Consultant Medical Oncologist, Rajeev Gandhi Cancer Institute & Research Center | |
Panelist 6 | DR. RAKESH CHOPRA | Sr. Director, Paras Hospitals Professor of Medicine, UNMC, Omaha, Nebraska | |
Panelist 7 |